WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $28.8 million in its fiscal fourth quarter.

The Watertown, Massachusetts-based company said it had a loss of $1.36 per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.16 per share.

The biotechnology company posted revenue of $14.6 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $18.4 million.

For the year, the company reported a loss of $116 million, or $5.48 per share. Revenue was reported as $67.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA